
This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.
Ann-Marie Idusuyi is a clinical specialist in infectious diseases at The Miriam Hospital Infectious Diseases and Immunology Center in Providence, Rhode Island. She is a member of Making a Difference in Infectious Diseases and the Society of Infectious Diseases Pharmacists. Her clinical interests include HIV, outpatient parenteral antimicrobial therapy, and treatment of infections
in immunocompromised hosts.
This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.